(S (NP (NP (DT The) (NN integration)) (PP (IN of) (NP (NN machine) (VBG learning) (NNS methods))) (PP (IN into) (NP (NNS bioinformatics)))) (VP (VBZ provides) (NP (JJ particular) (NNS benefits)) (PP (IN in) (S (VP (VBG identifying) (SBAR (WHADVP (WRB how)) (S (NP (NP (NNS therapeutics)) (ADJP (JJ effective) (PP (IN in) (NP (CD one) (NN context))))) (VP (MD might) (VP (VB have) (NP (NN utility)) (PP (PP (IN in) (NP (DT an) (JJ unknown) (JJ clinical) (NN context))) (CC or) (PP (IN against) (NP (DT a) (JJ novel) (NN pathology)))))))))))) (. .))
(S (NP (PRP We)) (VP (VBP aim) (S (VP (TO to) (VP (VB discover) (NP (NP (DT the) (JJ underlying) (NNS associations)) (PP (IN between) (NP (NP (JJ viral) (NNS proteins)) (CC and) (NP (NP (JJ antiviral) (NNS therapeutics)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADJP (JJ effective) (PP (IN against) (NP (PRP them))))))))))) (PP (IN by) (S (VP (VBG employing) (NP (JJ neural) (NN network) (NNS models))))))))) (. .))
(S (S (VP (VBG Using) (NP (NP (DT the) (NAC (NNP National) (NNP Center) (PP (IN for) (NP (NNP Biotechnology) (NNP Information)))) (NN virus) (NN protein) (NN database)) (CC and) (NP (NP (DT the) (NNP DrugVirus) (NN database)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ provides) (NP (NP (DT a) (JJ comprehensive) (NN report)) (PP (IN of) (NP (NP (NP (JJ broad-spectrum) (JJ antiviral) (NNS agents)) (PRN (-LRB- -LRB-) (NP (NNP BSAAs)) (-RRB- -RRB-))) (CC and) (NP (NP (VBZ viruses)) (SBAR (S (NP (PRP they)) (VP (VBP inhibit))))))))))))))) (, ,) (NP (PRP we)) (VP (VBD trained) (NP (NNP ANN) (NNS models)) (PP (IN with) (NP (NP (NP (JJ virus) (NN protein) (NNS sequences)) (PP (IN as) (NP (NNS inputs)))) (CC and) (NP (NP (JJ antiviral) (NNS agents)) (VP (VBD deemed) (S (ADJP (NNS safe-in-humans)))) (PP (IN as) (NP (NNS outputs))))))) (. .))
(S (NP (NNP Model) (NN training)) (VP (VP (VBD excluded) (NP (NNP SARS-CoV-2) (NNS proteins))) (CC and) (VP (VBD included) (ADVP (RB only)) (NP (NNP Phases) (NNP II) (, ,) (NX (NNP III)) (, ,) (NNP IV) (CC and) (NX (NNP Approved) (NN level) (NNS drugs))))) (. .))
(S (S (VP (VBG Using) (NP (NP (NNS sequences)) (PP (IN for) (NP (NP (NNP SARS-CoV-2)) (PRN (-LRB- -LRB-) (NP (NP (DT the) (NN coronavirus)) (SBAR (WHNP (WDT that)) (S (VP (VBZ causes) (NP (NNP COVID-19)))))) (-RRB- -RRB-))))) (PP (IN as) (NP (NP (NNS inputs)) (PP (TO to) (NP (DT the) (JJ trained) (NNS models))))))) (VP (VBZ produces) (NP (NP (NNS outputs)) (PP (IN of) (NP (NP (JJ tentative) (JJ safe-in-human) (JJ antiviral) (NNS candidates)) (PP (IN for) (S (VP (VBG treating) (NP (NNP COVID-19))))))))) (. .))
(S (NP (PRP$ Our) (NNS results)) (VP (VBP suggest) (NP (NP (JJ multiple) (NN drug) (NNS candidates)) (, ,) (SBAR (WHNP (NP (DT some)) (WHPP (IN of) (WHNP (WDT which)))) (S (VP (JJ complement) (NP (NP (JJ recent) (NNS findings)) (PP (IN from) (NP (JJ noteworthy) (JJ clinical) (NNS studies))))))))) (. .))
(S (NP (NP (PRP$ Our) (JJ in-silico) (NN approach)) (PP (TO to) (NP (NN drug) (NN repurposing)))) (VP (VBZ has) (NP (VBN promise)) (PP (IN in) (S (VP (VBG identifying) (NP (NP (JJ new) (NN drug) (NNS candidates)) (CC and) (NP (NP (NNS treatments)) (PP (IN for) (NP (JJ other) (NNS viruses))))))))) (. .))
